NGI+ – The Next-Generation Precision of APSD Testing

Revolutionize APSD Testing with the Next-Generation Impactor NGI+.
Unmatched Durability and Precise Data for Inhaler Testing.

For experts conducting Aerodynamic Particle Size Distribution (APSD) measurements, the NGI+ takes inhalation drug testing to the next level. Built upon the trusted Next Generation Impactor (NGI) design, the NGI+ features enhanced corrosion resistance, improved chemical compatibility, and extended equipment life - ensuring more reliable, repeatable APSD results across a wider range of formulations.

Why Choose NGI+ for APSD Testing?

• Precise APSD Characterization – Achieve accurate and reliable measurements with industry-leading impactor performance, supporting a wider range of drugs and delivery systems.
• Enhanced Durability – Featuring superior corrosion resistance and chemical compatibility, the NGI+ is ideal for testing nebulizers, dry powder, and high-saline formulations, ensuring long-term reliability.
• Robust Cleaning Options – Designed for automated cleaning and harsh cleaning agents, the NGI+ minimizes cross-contamination risks and reduces cleaning time.
• Seamless Integration – Easily upgrade your existing NGI system without workflow disruption, extending the lifespan of your equipment.

 

Real-World Applications of NGI+

• Nebulizer & Biologic Testing – Ideal for high-saline and protein-based formulations, providing reliable APSD data.
• Improved Method Robustness – The NGI+ reduces material degradation, offering consistent, high-quality APSD measurements over time.
• Faster, Safer Cleaning – Supports automated cleaning and chemical-based cleaning methods, reducing downtime and improving productivity.

 

Contact Us for More Information and Learn How NGI+ Enhances Your Lab’s Testing Capabilities!